Fragility Fractures of the Pelvis (FFP)

Description

Prospective data will be collected in approximately 420 patients, above the age of 65, suffering from an FFP type fracture equal to or higher than type II, according to Rommens and Hofmann. Patients will be followed up according to the standard (routine) for up to 1 year after the treatment. Data collection will include underlying disease, treatment details, functional and patient reported outcomes (PRO)s, radiological outcomes, and anticipated or procedure-related adverse events (i.e. complications).

Conditions

Pelvic Fracture

Talk to us

Study Overview

On this page

Study Details

Study overview

Prospective data will be collected in approximately 420 patients, above the age of 65, suffering from an FFP type fracture equal to or higher than type II, according to Rommens and Hofmann. Patients will be followed up according to the standard (routine) for up to 1 year after the treatment. Data collection will include underlying disease, treatment details, functional and patient reported outcomes (PRO)s, radiological outcomes, and anticipated or procedure-related adverse events (i.e. complications).

Fragility Fractures of the Pelvis: Observational Outcome Study

Fragility Fractures of the Pelvis (FFP)

Condition
Pelvic Fracture
Intervention / Treatment

-

Contacts and Locations

Columbia

University of Missouri, Columbia, Missouri, United States, 65203

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Age 65 years or older at time of injury
  • * Diagnosis, via CT scan as per standard of care, of FFP grade II or higher according to the Rommens and Hofmann classification (including fractures of the anterior pelvic ring involving the anterior lip of the acetabulum not regarded as the acetabular fractures)
  • * Informed consent obtained, ie:
  • * Ability to understand the content of the patient information/ICF
  • * Willingness and ability to participate in the registry according to the standard of care in each clinic
  • * Signed and dated Ethics Committee (EC)/ Institutional Review Board (IRB) approved written informed consent OR
  • * Written consent provided according to the IRB/EC defined and approved procedures for patients who are not able to provide independent written informed consent
  • * Pelvic fractures that do not meet the criteria of a fragility fracture (ie, high-energy trauma)
  • * FFP type I fractures
  • * Concomitant fractures of the acetabulum (except anterior lip of the acetabulum, see above)
  • * Pathological fractures (ie, patients with malignant or metastatic diseases of the pelvis, infections)
  • * Concomitant osteoporotic fractures outside of pelvis
  • * Participation in any other medical device or medicinal product study within the previous month that could influence in opinion of the PI the results of the present registry

Ages Eligible for Study

65 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

AO Innovation Translation Center,

Pol Maria Rommens, MD, PRINCIPAL_INVESTIGATOR, University Medical Center Johannes Gutenberg-University

Study Record Dates

2026-06